OOIR: Observatory of International Research

Papers

(The H4-Index of Human Vaccines & Immunotherapeutics is 41. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-04-01 to 2025-04-01.)

Article	Citations
Safety of Sars-Cov-2 vaccines administration for adult patients with hereditary fructose intolerance	338
Attitudes of school teachers toward influenza and COVID-19 vaccine in Greece during the COVID-19 pandemic	295
Beliefs and barriers of COVID-19 vaccination hesitancy among Sudanese healthcare workers in Sudan: A cross sectional study	255
Reasons underlying the intention to vaccinate children aged 5-11 against COVID-19: A cross-sectional study of parents in Israel, November 2021	144
COVID-19 vaccines associated with vasovagal malaise: A retrospective study in two mass vaccination centers and analysis of the WHO pharmacovigilance database	127
Human vaccines & immunotherapeutics: News October 2022	122
Effects of a web-based HPV vaccination intervention on cognitive outcomes among young gay, bisexual, and other men who have sex with men	116
Geographical and time trends of measles incidence and measles vaccination coverage and their correlation in Nigeria	116
Challenges to COVID-19 vaccine introduction in the Democratic Republic of the Congo – a commentary	94
Expanding access to COVID-19 testing, vaccination and treatment at a free clinic for uninsured Spanish-speaking adults in Providence, RI	84
Human vaccines & immunotherapeutics: News August 2022	76
Human Vaccines & immunotherapeutics: News, June 2022	74
Why the American Academy of Pediatrics recommends initiating HPV vaccine at age 9	70
Understanding barriers to influenza vaccination among parents is important to improve vaccine uptake among children	64
Immunogenicity and safety of a COVID-19 DNA vaccine in healthy adults and elderly: A randomized, observer-blind, placebo-controlled phase 2 trial	63
RNA vaccines: The dawn of a new age for tuberculosis?	60
Prevention of herpes zoster in acquired immunocompromised conditions: Review of updates and perspectives from Hong Kong	59
Assessment of COVID-19 vaccine take-up and its predictors among healthcare professionals in public hospitals, Addis Ababa, Ethiopia: Facility-based cross-sectional study	59
Evaluating the impact of the vaccination prescription program on herpes zoster vaccine coverage in Ningbo, China: An interrupted time series analysis	59
Patient preferences toward herpes zoster vaccination among individuals aged 50 years or older in South Korea: Findings from a discrete choice experiment	57
Intention to get COVID-19 vaccines: Exploring the role of attitudes, subjective norms, perceived behavioral control, belief in COVID-19 misinformation, and vaccine confidence in Northern India	57
Expanding vaccination provider types and administration sites can increase vaccination uptake: A systematic literature review of the evidence in non-United States geographies	57
A qualitative investigation of facilitators and barriers to accessing COVID-19 vaccines among Racialized and Indigenous Peoples in Canada	56
Hepatitis A and B vaccination in adults at risk: A survey of US healthcare providers’ attitudes and practices	56
Estimation of single-dose varicella vaccine effectiveness in South Korea using mathematical modeling	55

Willingness to accept COVID-19 vaccine among the elderly and the chronic disease population in China	54
Autologous dendritic cells loaded with antigens from self-renewing autologous tumor cells as patient-specific therapeutic cancer vaccines	52
Global research trends in CAR-T cell therapy for solid tumors: A comprehensive visualization and bibliometric study (2012–2023)	52
Acceptance of a COVID-19 vaccine and associated factors among pregnant women in China: a multi-center cross-sectional study based on health belief model	52
60 Years of viral vaccines	50
Influenza vaccine coverage in 6months-64 years-old patients affected by chronic diseases: A retrospective cohort study in Italy	50
Vaccine manufacturing is essential to ensure access	46
A systematic review and meta-analysis of the seroconversion rates and adverse effects of COVID-19 mRNA vaccine and COVID-19 viral vector vaccine in kidney transplant recipient patients	46
Heterologous mRNA-based COVID-19 booster strategies: Comment	45
Predictive factors of neoadjuvant immune checkpoint blockade in melanoma	45
Willingness of college students to receive COVID-19 heterologous vaccination in Taizhou, China	45
Assessment of mumps-containing vaccine effectiveness by dose during 2006 to 2020 in Quzhou, China	45
Phase 3 trial to evaluate the safety, tolerability, and immunogenicity of V114, a 15-valent pneumococcal conjugate vaccine, followed by 23-valent pneumococcal polysaccharide vaccine 6 months later, in	43
Impaired long-term anti-HBs responses in choronic hepatitis C patients: Results from a five-year follow-up study with healthy control	43
Integrating civil liberty and the ethical principle of autonomy in building public confidence to reduce COVID-19 vaccination inequity in Africa	42
Reply to the letter to the editor titled “Guillain-Barre / Miller-Fisher overlap syndrome or acute, motor and sensory, axonal neuropathy with cranial nerve involvement?”	41